ECM5 Antibody

Shipped with Ice Packs
In Stock

Description

CEACAM5 Biological Context

CEACAM5 (CD66e) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein belonging to the CEACAM family. Key characteristics include:

PropertyDescription
StructureN-terminal IgV-like domain + six IgC2-like domains + GPI anchor
ExpressionOverexpressed in 90% of colorectal, pancreatic, and gastrointestinal cancers
FunctionMediates cell adhesion via homophilic/heterophilic interactions; inhibits anoikis
Clinical SignificanceBiomarker for metastasis detection and post-surgical monitoring

Anti-CEACAM5 Monoclonal Antibodies

Several anti-CEACAM5 antibodies with therapeutic potential have been developed:

mAb CC4

  • Generation: Produced by immunizing mice with live LS174T colorectal cancer cells .

  • Specificity: Binds strongly to colorectal adenocarcinoma tissues .

  • Therapeutic Efficacy:

    • Reduces tumor growth in xenografted mice by 60–70% .

    • Demonstrates high tumor-specific accumulation in vivo .

5G2 Antibody

  • Generation: Developed using primary-cultured colorectal cancer spheroids .

  • Mechanism: Targets glycan structures on CEACAM5/CEACAM6; disrupts integrin β4 signaling .

  • Functional Impact:

    • Inhibits cell adhesion by 40–50% in colorectal cancer models .

    • Does not directly interact with integrins but alters their membrane localization .

Clinical Trials of CEACAM5-Targeting Antibodies

While no trials for "ECM5" exist, related antibodies against CEACAM family members have been tested:

AntibodyTargetPhaseOutcome (Clinical Trial Data)Citation
E5EndotoxinIIINo mortality reduction in sepsis; improved organ failure resolution
CC4CEACAM5Precl.70% tumor growth inhibition in colorectal cancer models

Technical Advancements in Antibody Development

Recent methodologies enhance antibody generation and diversification:

  • Recombinant Antibody Production:

    • Yields up to 2.0 mg/mL from 30 mL Expi293F cell cultures .

    • Enables species specificity customization and fragment engineering (e.g., scFv to full IgG) .

  • ECM Scaffold Delivery:

    • Extracellular matrix (ECM)-assisted vaccines improve antigen exposure, curing 50–75% of lymphoma tumors in mice .

Challenges and Future Directions

  • Specificity Issues: Cross-reactivity with CEACAM6 complicates therapeutic targeting .

  • Glycan Dependency: Antibodies like 5G2 require intact glycosylation for binding .

  • Clinical Translation: No anti-CEACAM5 antibodies have progressed beyond preclinical trials as of 2025 .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ECM5 antibody; YMR176W antibody; YM8010.06Protein ECM5 antibody; Extracellular matrix protein 5 antibody
Target Names
ECM5
Uniprot No.

Target Background

Function
ECM5 Antibody may play a role in cell wall organization and biogenesis.
Database Links

KEGG: sce:YMR176W

STRING: 4932.YMR176W

Subcellular Location
Nucleus.

Q&A

What is ECM5 protein and why is it significant in yeast research?

ECM5 (Extra Cellular Mutant 5) is a protein found in Saccharomyces cerevisiae that plays roles in chromatin regulation and cellular processes. Understanding ECM5 function contributes to fundamental knowledge about eukaryotic gene regulation and cellular responses to environmental conditions. Research utilizing ECM5 antibodies can help elucidate these pathways through detection and quantification of the protein in various experimental conditions.

What are the recommended storage conditions for ECM5 antibody?

ECM5 antibody should be stored at -20°C or -80°C upon receipt . Repeated freeze-thaw cycles should be avoided as they can compromise antibody function. For working solutions, aliquoting the antibody and storing the aliquots is recommended to maintain integrity and functionality of the antibody over time.

What applications has the ECM5 antibody been validated for?

According to the available data, ECM5 antibody has been tested and validated for ELISA and Western blotting applications . When planning experiments, researchers should consider these validated applications first, while being aware that optimization might be required for their specific experimental conditions.

How can specificity of the ECM5 antibody be verified in experimental systems?

To verify specificity, researchers should consider:

  • Performing blocking experiments with recombinant ECM5 protein

  • Using ECM5 knockout/deletion strains as negative controls

  • Testing cross-reactivity with related proteins

  • Comparing results from multiple antibody clones or sources

The polyclonal nature of available ECM5 antibodies means they recognize multiple epitopes, potentially increasing sensitivity but requiring careful validation of specificity.

What are the potential pitfalls when using ECM5 antibody in yeast cell lysates?

When working with yeast cell lysates, researchers should consider:

ChallengeSolution
Cell wall interferenceOptimize lysis buffers with appropriate enzymes (lyticase, zymolyase)
High backgroundUse blocking agents specific for yeast proteins (e.g., 5% non-fat milk with yeast lysate pre-absorption)
Protein degradationInclude appropriate protease inhibitors specific for yeast proteases
Low signalConsider enrichment techniques before antibody application

Careful sample preparation is essential for successful detection of ECM5 in yeast systems.

How can ECM5 antibody be used to study protein-protein interactions?

For studying ECM5 protein interactions, researchers could:

  • Perform co-immunoprecipitation followed by mass spectrometry

  • Use the antibody in chromatin immunoprecipitation (ChIP) assays to identify DNA binding sites

  • Employ proximity ligation assays (PLA) for in situ detection of protein complexes

  • Conduct yeast two-hybrid screens with validation using the antibody

When developing such methods, optimization of antibody concentration and buffer conditions would be critical for success.

How can Western blot protocols be optimized for ECM5 detection?

For optimal Western blot detection of ECM5:

  • Sample preparation: Use denaturing conditions with SDS and reducing agents; optimize lysis buffers for yeast cells

  • Gel selection: Consider the predicted molecular weight of ECM5 (~185 kDa) when selecting gel percentage

  • Transfer conditions: Longer transfer times or specialized methods for higher molecular weight proteins

  • Antibody dilution: Start with manufacturer recommendations (typically 1:1000) and optimize

  • Detection system: Enhanced chemiluminescence systems typically provide good sensitivity

The antibody's specific storage buffer (50% Glycerol, 0.01M PBS, pH 7.4 with 0.03% Proclin 300) should be considered when calculating final dilutions.

What controls are essential when using ECM5 antibody in immunofluorescence?

Although immunofluorescence is not specifically listed among tested applications for the ECM5 antibody in the available data , researchers attempting this application should implement:

  • Positive control: Wild-type yeast cells with known ECM5 expression

  • Negative control: ECM5 deletion strain or cells treated with ECM5 siRNA

  • Secondary antibody-only control: To assess non-specific binding

  • Pre-absorption control: Pre-incubating antibody with recombinant ECM5

  • Peptide competition: Using the immunizing peptide to block specific binding

These controls help distinguish true signal from background and confirm antibody specificity.

How do different fixation methods affect ECM5 antibody performance?

Different fixation methods can significantly impact epitope accessibility:

Fixation MethodAdvantagesConsiderations for ECM5 Detection
ParaformaldehydePreserves morphologyMay mask epitopes, requiring retrieval
MethanolGood for nuclear proteinsCan destroy some epitopes
AcetoneMinimal epitope maskingMay not preserve cellular structures
GlutaraldehydeStrong fixationHigh autofluorescence, potential epitope alteration

Researchers should test multiple fixation protocols when establishing ECM5 detection methods.

How can ECM5 antibody be used to study chromatin regulation in yeast?

To study ECM5's role in chromatin regulation:

  • Chromatin immunoprecipitation (ChIP) assays to identify DNA binding sites

  • Co-immunoprecipitation with histone modifiers and chromatin remodelers

  • Immunofluorescence to examine nuclear localization under different conditions

  • Western blotting to assess protein levels during different cell cycle stages

These approaches should be complemented with functional assays to correlate ECM5 binding with biological outcomes.

What considerations are important when designing quantitative experiments with ECM5 antibody?

For quantitative applications:

  • Establish a standard curve using recombinant ECM5 protein

  • Determine the linear range of detection for the antibody

  • Use appropriate normalization controls (housekeeping proteins)

  • Consider the impact of post-translational modifications on antibody recognition

  • Account for potential lot-to-lot variations by testing each new antibody lot

Quantitative comparisons should always be performed with samples processed identically and ideally on the same blot or plate.

How can ECM5 antibody be used alongside genetic approaches to study ECM5 function?

Integration of antibody-based detection with genetic approaches enhances research rigor:

  • Confirm knockout efficiency in deletion strains via Western blotting

  • Verify tagged constructs expression and functionality

  • Assess localization changes in mutant strains

  • Monitor protein levels in response to genetic perturbations

  • Validate genetic interaction findings with protein interaction studies

This combined approach provides multiple lines of evidence for ECM5 function and regulation.

What approaches could expand the utility of ECM5 antibodies beyond current applications?

Potential advanced applications include:

  • Super-resolution microscopy to examine sub-nuclear localization

  • Live-cell imaging using antibody fragments

  • Antibody-based proximity labeling for proteomic analysis

  • ELISA-based high-throughput screening of ECM5 modulators

  • Single-cell Western blotting for heterogeneity analysis

Each application would require specific optimization and validation strategies.

How might ECM5 antibodies contribute to comparative studies across fungal species?

For cross-species analysis:

  • Test cross-reactivity with ECM5 homologs in related fungal species

  • Use epitope mapping to identify conserved regions

  • Consider developing pan-ECM5 antibodies targeting highly conserved domains

  • Implement computational approaches to predict cross-reactivity

Such studies could reveal evolutionary conservation of ECM5 function and regulation.

What technical innovations could improve ECM5 detection sensitivity and specificity?

Emerging technologies that could enhance ECM5 research include:

  • Single-molecule detection methods

  • Nanobody development for improved penetration

  • Multiplex imaging with other chromatin regulators

  • Mass cytometry for single-cell protein quantification

  • Recombinant antibody technologies for improved reproducibility

Researchers should monitor the literature for developments in these areas that could be applied to ECM5 studies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.